The oral KIF11 inhibitor 4SC-205 exhibits antitumor activity and potentiates standard and targeted therapies in primary and metastatic neuroblastoma models
口服KIF11抑制剂4SC-205具有抗肿瘤活性，并能增强原发性和转移性神经母细胞瘤模型中的标准疗法和靶向疗法的疗效。
期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.533
Masanas, Marc; Masiá, Nuria; Suárez-Cabrera, Leticia; Olivan, Mireia; Soriano, Aroa; Majem, Blanca; Devis-Jauregui, Laura; Burgos-Panadero, Rebeca; Jiménez, Carlos; Rodriguez-Sodupe, Pau; Boloix, Ariadna; Toledano, Ignasi; Guillén, Gabriela; Navarro, Alexandra; Llobet-Navas, David; Villanueva, Alberto; Sánchez de Toledo, Josep; Roma, Josep; Noguera, Rosa; Moreno, Lucas; Krauss, Rolf; Gallego, Soledad; Santamaria, Anna; Segura, Miguel F
